Medicalgorithmics S.A.
MDG.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.38 | 0.61 | 1.45 | -0.07 |
| FCF Yield | -0.04% | -1.30% | -1.36% | -2.72% |
| EV / EBITDA | -144.30 | -325.49 | -81.52 | -47.71 |
| Quality | ||||
| ROIC | -4.09% | -2.00% | -3.99% | -5.20% |
| Gross Margin | -29.27% | 2.24% | 81.61% | 87.06% |
| Cash Conversion Ratio | 0.01 | 1.24 | 0.11 | 0.31 |
| Growth | ||||
| Revenue 3-Year CAGR | -18.29% | -24.20% | -31.53% | -35.99% |
| Free Cash Flow Growth | 95.70% | 8.57% | 23.18% | 26.48% |
| Safety | ||||
| Net Debt / EBITDA | -5.93 | -15.97 | -0.75 | 0.39 |
| Interest Coverage | -6.16 | -4.36 | -15.69 | -77.53 |
| Efficiency | ||||
| Inventory Turnover | 1.40 | 0.99 | 0.16 | 0.08 |
| Cash Conversion Cycle | 117.23 | 159.07 | 461.79 | 941.96 |